Immunity to Hepatitis-A virus: A nationwide population-based seroprevalence study from Iran.

CONCLUSIONS: This study showed that Iran is among HAV low endemic countries and vaccination against HAV is recommended only in the high-risk population, including patients with chronic liver diseases, patients with coagulopathy, travelers to the high endemic areas, and homosexuals. Establishment of national HAV surveillance system, concerning of health system about the occurrence of the HAV outbreaks, implementation of harm reduction strategies, improving economic indices and sanitation and access to the safe water in the deprived regions is recommended.
PMID: 32917416 [PubMed - as supplied by publisher]

Source: Vaccine - September 7, 2020 Category: Allergy & Immunology Authors: Lankarani KB, Honarvar B, Molavi Vardanjani H, Kharmandar A, Gouya MM, Zahraei SM, Baneshi MR, Ali-Akbarpour M, Kazemi M, Seif M, Fard SAZ, Emami A Tags: Vaccine Source Type: research